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Abstract
Filamentous fungi are an important cause of pulmonary and systemic morbidity and mortality, and also cause corneal
blindness and visual impairment worldwide. Utilizing in vitro neutrophil killing assays and a model of fungal infection of the
cornea, we demonstrated that Dectin-1 dependent IL-6 production regulates expression of iron chelators, heme and
siderophore binding proteins and hepcidin in infected mice. In addition, we show that human neutrophils synthesize
lipocalin-1, which sequesters fungal siderophores, and that topical lipocalin-1 or lactoferrin restricts fungal growth in vivo.
Conversely, we show that exogenous iron or the xenosiderophore deferroxamine enhances fungal growth in infected mice.
By examining mutant Aspergillus and Fusarium strains, we found that fungal transcriptional responses to low iron levels and
extracellular siderophores are essential for fungal growth during infection. Further, we showed that targeting fungal iron
acquisition or siderophore biosynthesis by topical application of iron chelators or statins reduces fungal growth in the
cornea by 60% and that dual therapy with the iron chelator deferiprone and statins further restricts fungal growth by 75%.
Together, these studies identify specific host iron-chelating and fungal iron-acquisition mediators that regulate fungal
growth, and demonstrate that therapeutic inhibition of fungal iron acquisition can be utilized to treat topical fungal
infections.
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Introduction
Aspergillus and Fusarium are filamentous fungi that cause lethal
infections in immune suppressed individuals [1,2]. Additionally,
they infect the corneas of immunocompetent individuals, and are a
major cause of blindness associated with ocular trauma [3,4].
Although less common, Curvularia, Alternaria, and Penicillium species
also cause keratitis [3]. Globally, the world health organization
estimates that 1.8 million people in developing nations are blinded
annually from corneal ulcers; furthermore, in developing nations,
up to 65% of total corneal ulcers are caused by fungal infection,
with approximately 1 million cases occurring annually in Asia and
Africa [5–7].
Treatment regimens for fungal keratitis are often ineffective,
with up to 60% of fungal keratitis cases requiring corneal
transplantation [3]. Given the limited treatment options, there is
a pressing need to develop new treatment strategies. In this effort,
we recently demonstrated that inhibitors of fungal anti-oxidative
responses enhanced fungal clearance in vivo and improved disease
outcome [8]. As iron is essential for the redox reactions of major
fungal antioxidants, including thioredoxin-dependent peroxire-
doxases [9,10], and fungal iron acquisition mutants are more
susceptible to oxidative stress [11], we hypothesized that targeting
fungal iron acquisition may represent a potential new avenue for
treatment of fungal infections.
Fungal iron acquisition primarily involves the production of
hydroxamate-type siderophores that are secreted into the
environment, bind iron with high affinity, and are then captured
by specific siderophore receptors on the fungal cell membrane
[12]. Specifically, the A. fumigatus siderophore biosynthesis
pathway originates with the sidA gene, which encodes ornithine-
N5-oxygenase, resulting in conversion of ornithine to N5-hydro-
xyornithine [13]. Utilizing this essential precursor, the siderophore
biosynthesis pathway leads to either intracellular or extracellular
siderophores. The sidC gene product is required for production of
the intracellular siderophores, ferricrocin (FC) and hydroxyferri-
crocin (HFC), whereas the sidF and sidD gene products are
required for production of the extracellular siderophores, fusar-
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inine C (FusC) and triacetylfusarinine C (TAFC) [13]. The sidG
gene product is required to generate TAFC from FusC [13],
whereas both the sidH and sidI gene products are required to
incorporate mevalonate into the structure of extracellular side-
rophores [14]. As mevalonate biosynthesis is dependent on HMG-
CoA reductase and this enzyme is inhibited by statins, we
hypothesized that statin-mediated inhibition of fungal HMG-CoA
reductase may restrict fungal iron acquisition in vivo.
Fungal siderophores are secreted into mammalian tissues during
infection where they compete with host iron sequestration
defenses. Under homeostatic conditions, free iron is maintained
at relatively low levels by iron-binding proteins such as transferrin
and ferritin [15]. In addition, mucosal secretions contain high
concentrations of lactoferrin, which binds iron, and lipocalin-1,
which sequesters fungal siderophores [16,17]. However, tissue
damage during infection increases extracellular iron levels by
releasing intracellular labile iron, ferritin, and heme-containing
proteins [18]. Infection also stimulates both local and systemic
immune defenses to counter microbial iron acquisition. Resident
cells can secrete iron-sequestering proteins and chemotactic
cytokines, which recruit neutrophils to the site of infection.
Neutrophils also release pre-formed and de novo synthesized iron
sequestering proteins such as lactoferrin, Lcn-2, and the hemo-
globin binding protein haptoglobin [19]. Furthermore, neutrophil-
mediated oxidation is likely to increase the microbial requirement
for iron to fuel iron-dependent anti-oxidative defenses. Lastly,
production of cytokines such as IL-6 and IL-22 can induce local
and systemic synthesis of the peptide hormone hepcidin, which
degrades the iron exporter ferroportin and traps iron inside host
cells [20–22].
In the current study, we examined the role of host iron
sequestration and fungal iron acquisition in a murine model of
Aspergillus and Fusarium corneal infection. We show that Dectin-1
and IL-6 regulate expression of genes involved in iron sequestra-
tion and that fungal growth positively correlates with serum iron
levels. Using mutant A. fumigatus and F. oxysporum strains, we also
demonstrate that fungal transcriptional responses to low iron levels
and mevalonic acid-dependent extracellular siderophore biosyn-
thesis, but not intracellular siderophores or reductive iron
assimilation, are essential for fungal growth in vitro and during
infection. Lastly, using iron chelators, siderophore binding
proteins, and siderophore biosynthesis inhibitors including statins
we provide proof-of-concept that targeting fungal iron acquisition
enhances fungal clearance from infected tissues and may represent
a new avenue for treatment of fungal infections.
Results
Dectin-1 and IL-6 regulate local and systemic
endogenous host iron-sequestration pathways
As we previously showed that Dectin-1 mediates neutrophil
recruitment into the cornea during Aspergillus infection [23], and
IL-6 is known to mediate hepatic hepcidin production [15], we
examined the role of Dectin-1 and IL-6 in iron-sequestration
during fungal infection. To determine if fungal infection of the
cornea initiates an iron-sequestration response, we infected
C57BL/6, Dectin-12/2, and IL-62/2 mice intrastromally with
A. fumigatus dsRed conidia as described [8]. After 10 h, corneas
were dissected and homogenized, and IL-6 was quantified by
ELISA. Figure 1A shows increased IL-6 in the corneas of infected
compared with naı̈ve C57BL/6 mice at 10 h post-infection;
however, IL-6 was not significantly elevated in Dectin-12/2
corneas. Serum IL-6 was undetectable in naı̈ve C57BL/6 mice;
however, at 24 h post-infection serum IL-6 increased to 400rg/ml
in infected C57BL/6 mice (Figure 1B). As hepcidin expression is
induced by IL-6 [15], we examined hepcidin expression in livers of
infected C57BL/6 and IL-62/2 mice at 24 h post-infection.
Figure 1C shows that hepcidin expression was elevated 10-fold in
infected compared with naı̈ve C57BL/6 mice, whereas expression
was significantly lower in infected IL-62/2 mice.
During fungal infection of humans and mice, neutrophils
comprise .95% of the cellular infiltrate in the cornea and are
likely the predominant source of gene transcripts [23,24].
Therefore, prior to examining de novo transcription of iron-
sequestering genes during infection we first quantified the number
of neutrophils infiltrating C57BL/6 and IL-62/2 infected corneas
by flow cytometry using the Ly6G NIMP-R14 monoclonal
antibody. As shown in Figure 1D, there was no significant
difference in neutrophil numbers between infected C57BL/6 and
IL-62/2 mice. RNA was then isolated from C57BL/6 and
IL-62/2 corneas at 24 h post-infection, and gene expression was
measured by Q-PCR.
Compared with naı̈ve C57BL/6 corneas, expression of the iron
chelating protein transferrin (TF) was up-regulated 10-fold,
transferrin receptor 2 (TR2) expression was up-regulated 400-
fold, and lactoferrin receptor/intelectin-1 (LR) was elevated 3-fold
in infected corneas (Figure 1E). In contrast, these genes were not
elevated in infected IL-62/2 corneas. Lactoferrin and transferrin
receptor 1 expression were not elevated in C57BL/6 corneas, most
likely due to these proteins being pre-formed in neutrophils [19].
During infection, lysed cells release heme, which microbes can
utilize as a source of iron [18]. To restrict microbial access to
heme, mammals produce hemopexin (Hpx) that binds to heme,
and haptoglobin (HptG), which binds hemoglobin [15]. Figure 1E
also shows that expression of Hpx and HptG in infected C57BL/6
mice is up-regulated 200-fold compared with naı̈ve mice, whereas
expression is ,10-fold increased in infected IL-62/2 mice.
In a low iron environment, microbial siderophores bind iron
with high affinity and are subsequently internalized through
siderophore transporters on the fungal cell membrane [12,25].
Humans encode lipocalin-1 (Lcn-1) and lipocalin-2 (Lcn-2),
whereas mice only express Lcn-2 [26]. Both Lcn-1 and Lcn-2
Author Summary
Fungal pathogens, in addition to causing life-threatening
systemic disease, can also invade the cornea and cause
blindness and visual impairment. In the current study, we
examined the role of iron acquisition in corneal infections
caused by Aspergillus and Fusarium. We first demonstrated
that expression of iron chelators, heme, siderophore
binding proteins and hepcidin is elevated in infected
corneas. Secondly, we showed impaired in vivo growth in
Aspergillus and Fusarium with mutations in the pathway
leading to production of iron-binding siderophores. These
mutants were also more susceptible to killing by human
neutrophils. Based on these observations, we targeted
these pathways using topical iron chelators and found that
they blocked fungal growth in the cornea. Finally, as
statins target the enzyme HMG-CoA reductase, which is
required for siderophore and ergosterol biosysnthesis, we
found that topical statins inhibited fungal growth and
reduced infection, and showed that combined treatment
with the iron chelator deferiprone and statins had an
additive effect on fungal infection. Together, these studies
demonstrate that therapeutic inhibition of fungal iron
acquisition can be utilized to treat topical fungal
infections.
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bind to bacterial siderophores, but only Lcn-1 binds fungal
hydroxamate-type siderophores [17,26]. We found that in infected
C57BL/6 corneas, Lcn-2 expression is elevated 600-fold com-
pared with 2-fold in IL-62/2 mice (Figure 1E).
Although hepcidin is produced systemically by the liver, it is also
produced by neutrophils and monocytes after stimulation with IL-
6, or by iron-bound transferrin-mediated activation of the
transferrin receptor 2/human hemochromatosis protein (HFE)
complex [15]. Further, hepcidin induction is increased synergis-
tically by bone-morphogenetic protein (BMP)-mediated activation
and signaling through a hemojuvelin/BMP receptor complex [15].
Figure 1E shows that many of the proteins involved in non-
inflammatory induction of hepcidin are up-regulated at 24 h post-
infection, including HFE protein (200-fold), BMP2 (200-fold),
BMP-4 (30-fold), BMP-6 (10-fold), the BMP receptors: alk1 (2000-
fold) alk2 (300-fold), actr2A (300-fold), and hemojuvelin (300-fold).
Interestingly, local hepcidin transcript is only 2-fold up-regulated
at 24 h post-infection. In addition, ferroportin transcripts are up-
regulated 250-fold during infection (Figure 1E), which may be a
secondary response following hepcidin-mediated ferroportin deg-
radation. Figure 1E shows that the transcription of all the
hepcidin genes analyzed, except BMP-4, were significantly lower
in infected IL-62/2 mice compared to infected C57BL/6 mice.
Lcn-1 binds to many hydrophobic molecules including phospholip-
ids at the air-fluid interface in tears [27]. However, Lcn-1 also binds to
fungal hydroxamate-type siderophores [17]. Given that human
neutrophils store the bacterial-siderophore binding protein Lcn-2 in
secondary granules [19], we examined if human neutrophils also
produce Lcn-1. Peripheral blood neutrophils (.95% purity) from three
healthy human volunteers were incubated for 1 h in RPMI media in
the presence or absence of A. fumigatus crude hyphal extract, and Lcn-1
expression was examined by Q-PCR. As shown in Figure 1F, Lcn-1
gene expression was detected in human neutrophils in the presence or
absence of Aspergillus hyphal extract, indicating constitutive RNA
expression. Taken together, results from this set of studies indicate that
following fungal infection of the cornea, Dectin-1 dependent IL-6
production induces local and systemic host responses that limit
microbial access to iron.
Figure 1. Expression of local and systemic iron-sequestration proteins in Aspergillus fumigatus infected corneas. A. IL-6 production in
corneas of C57BL/6 and Dectin-12/2 mice 10 h after infection with A. fumigatus. B. Serum IL-6 at 24 h post-infection was quantified by ELISA C. Total
liver hepcidin gene expression was quantified using qPCR 24 h after corneal infection. D. Total neutrophil numbers in corneas of C57BL/6 and IL-62/2
mice 24 h post-infection. Neutrophils were incubated with the Ly6G NIMP-R14 Ab, and examined by flow cytometry. (Data points represent
individual corneas) E. RNA was extracted from corneas of infected mice 24 h post-infection, and genes encoding proteins involved in iron chelation,
heme or siderophore sequestration, and hepcidin signaling were examined by qPCR. F. Lcn-1 gene expression in peripheral blood neutrophils from
healthy volunteers after 2 h incubation with crude hyphal extract (CHE). (Data in panels A, B, C and E are mean +/2 SD of 5 mice per group; Data in
panel F are from three separate human donors). Abbreviations: B6-C57BL/6, CHE- crude Aspergillus hyphal extract, D1-Dectin-1, Lf-lactoferrin, Tf-
transferrin, LR- lactoferrin receptor, TR- transferrin receptor, HptG- haptoglobin, Hpx- hemopexin, Lcn-lipocalin, HFE- human hemochromatosis
protein, BMP-bone morphogenetic protein, Alk-activin receptor-like kinase, Actr-actin-related protein, HJV- hemojuvelin, HAMP-hepcidin, Fpt-
ferroportin.
doi:10.1371/journal.ppat.1003436.g001
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Iron availability regulates hyphal growth and the severity
of A. fumigatus infection
Given that fungal infection initiates an iron sequestration
response, we next examined if iron availability regulates fungal
growth during infection. Mice were injected intraperitoneally with
5 mg Fe-dextran (90 mmoles iron) or deferroxamine (5 mg), which
is an iron-chelating xenosiderophore that is utilized by A. fumigatus
[28]. Twenty four hours after the last injection, RFP-expressing A.
fumigatus (Af-dsRed) conidia were injected into the corneal stroma
of C57BL/6 mice [8,23]. After 24 h, total serum iron was
quantified in treatment and control groups.
Figure 2A shows that serum iron levels in infected mice were
reduced 2-fold compared with naı̈ve mice, indicating systemic
iron-sequestration during inflammation [15]. In contrast, mice
given systemic Fe-dextran, but not deferroxamine had significantly
elevated serum iron compared to vehicle-treated mice. Despite the
difference in serum iron levels, Figures 2B,C show that whereas
fungal mass (dsRed) increases over 48 h in vehicle-treated mice,
this was significantly higher in Fe-dextran and deferroxamine-
treated mice. Consistent with these data, Figure 2D shows that at
48 h post-infection, CFU were significantly higher in Fe-dextran
and deferroxamine-treated mice compared with control, vehicle-
treated mice. As filamentous fungi grow by hyphal extension and
not cell division, the dsRed measure of fungal mass increases over
time, whereas CFU decreases from the initial inoculum [15].
Figures 2B, E, and F show that corneal opacification was also
increased in Fe-dextran and deferroxamine-treated mice com-
pared to vehicle-treated mice, consistent with increased fungal
growth. The increased fungal growth in deferroxamine treated
mice is likely due to its xenosiderophore function, which can be
used by Aspergillus for iron acquisition [28].
To examine the effect of limiting iron availability during
infection, C57BL/6 corneas were infected with A. fumigatus dsRed
conidia as described (12), and the iron chelating protein lactoferrin
was added topically (10.4 mg in 8 ml) at 0 h and 6 h post-infection.
As shown in Figures 2G–I, infected corneas given topical
lactoferrin had significantly less fungal mass (dsRed) and CFU per
eye at 24 h post-infection compared with those given vehicle
alone. Taken together with results from Fe-dextran and deferrox-
amine-treated mice, these studies demonstrate that fungal growth
in the cornea is dependent on increased free iron or bio-available
iron.
Siderophores and detection of low iron concentrations
but not reductive iron assimilation is required for fungal
growth during infection
Given that fungal growth during infection is enhanced by the
exogenous xenosiderophore deferroxamine, we next examined the
role of endogenous fungal siderophores using A. fumigatus, F.
oxysporum, and Alternaria brassicicola iron acquisition mutants. The A.
fumigatus DsidA mutant does not synthesize extracellular or
intracellular siderophores [29], whereas the DhapX strain lacks
the transcription factor HapX that is activated by low iron
concentrations, and which regulates expression of genes involved
in iron acquisition including siderophores and repression of iron-
dependent pathways [30].
Figure 3A shows no significant difference in fungal growth in
media alone between the parent (WT) strain and the DsidA and
DhapX mutants, indicating that there is no effect of these mutations
on fungal growth in the presence of an exogenous source of iron.
We next examined the growth of the WT strain and the DsidA and
DhapX mutants in the presence of neutrophils, which we recently
showed kill hyphae by producing reactive oxygen species [8].
Conidia (spores; 12,500) were cultured 4–6 h in SDB media to
allow germination and production of hyphae and incubated with
16105 neutrophils. In contrast to RPMI media alone in which all
strains grew equally, in the presence of human neutrophils, growth
of the DsidA and DhapX mutants was significantly less than the WT
parental strain (Figure 3A), indicating that adaptation to iron
starvation and siderophores, which requires SidA and HapX is
essential for survival in the presence of neutrophils.
Consistent with a role for these genes in virulence, we found that
at 48 h post-infection, corneas infected with the A. fumigatus
mutant strains DsidA or DhapX had significantly lower CFU
compared with the parent strain (Figure 3B). Figure S1 shows
that corneas infected with the complemented DsidA strain sidAR or
the complemented DhapX strain hapXR, show no significant
difference in opacification or CFU as the WT parental strain. In
contrast, although the DftrA mutant lacks a membrane-bound iron
transport channel protein and is therefore deficient in cellular
uptake of environmental iron [29], there was no significant
difference in CFU in this mutant, indicating that this transporter
protein is not essential for fungal growth in vivo. Similarly,
Figures 3C, E, and F show that mice infected with the DsidA or
DhapX mutants have significantly less corneal opacification than
the parent A. fumigatus strain, whereas the DftrA mutant was not
significantly different. Histological analysis shows a pronounced
cellular infiltrate and fungal hyphae in the corneas of mice infected
with the parent strain, whereas no hyphae were detected in DsidA
infected corneas, indicating that these mutants did not germinate
in the cornea (Figure 3D). As with A. fumigatus, mice infected with
the F. oxysporum DhapX strain also exhibit significantly lower CFU
than the parent strain at 48 h post-infection (Figure 3G), and A.
brassicicola siderophore mutants have significantly less CFU than
the parent strain (Figure S2). Figure 3H–J demonstrate that
mice infected with the F. oxysporum DhapX strain also exhibit
significantly less corneal opacification compared to the parental
strain. Figure S1 shows that corneas infected with the Fusarium
complemented DhapX strain hapXR show no significant pheno-
typic differences from the WT parental strain. Taken together,
these data indicate that siderophores have a critical role in fungal
growth during infection, whereas reductive iron assimilation is not
essential.
Extracellular siderophores are required for fungal
infection
To determine the relative contribution of intracellular versus
extracellular siderophores in fungal keratitis, corneas were infected
with the DsidF and DsidC mutants. Figure 4B shows that CFU
from corneas infected with the DsidF mutant that leads to
extracellular siderophore production was significantly lower than
those infected with WT A. fumigatus, having a similar CFU as DsidA
mutants. In contrast, DsidC mutants that regulate production of
intracellular siderophores were not significantly different from the
parent strain. Consistent with this finding, corneas infected with
DsidF had significantly lower cornea opacity area and intensity
values compared with mice infected with WT A. fumigatus, whereas
DsidC mutants were not significantly different (Figure 4C–E).
Together, these findings indicate that extracellular, but not
intracellular siderophores are essential for fungal growth in the
cornea and development of keratitis.
To determine the relative contribution of the extracellular
siderophores FusC and TAFC, we infected corneas with DsidD
mutants, which do not produce extracellular siderophores, or
with DsidG mutants, which produce FusC but not TAFC, and
compared them with the parent A. fumigatus strain that produces
both FusC and TAFC [13]. Figure 4B shows that mice infected
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with DsidD mutants had significantly lower CFU compared with
WT A. fumigatus, whereas DsidG were not significantly different.
Corneal opacification scores reflected the CFU data, with DsidD
but not DsidG mutants having significantly less opacification
than WT A. fumigatus (Figure 4C–E). These findings indicate
that sidD-mediated synthesis of FusC rather than sidG-mediated
synthesis of TAFC is necessary and sufficient to support fungal
growth in vivo. Figure S1 shows that corneas infected with the
complemented strains sidFR and sidDR show no phenotypic
differences from the WT parental strain. Figure S2 shows that
both intracellular and extracellular siderophore mutants of
Alternaria brassicicola also have impaired growth during infection.
Together, these data clearly demonstrate that extracellular
siderophores are essential for both Aspergillus and Alternaria
growth during tissue infection, and that even though TAFC is
reportedly more stable [13], FusC production is sufficient to
maintain fungal growth in vivo.
Mevalonate incorporation into extracellular siderophores
is required for fungal infection
Fungal extracellular siderophore biosynthesis requires HMG-
CoA reductase-dependent synthesis of the precursor mevalonate
[14]. The Aspergillus genes sidI and sidH encode a CoA-ligase and
an enoyl-CoA-hydratase, respectively, which convert mevalonic
acid to anhydromevalonyl CoA and incorporate this precursor
through the sidF-D-G pathway into the structure of fusarinine C
and TAFC (Figure 5A) [13,14].
Figure 2. The effect of iron dextran, deferroxamine and lactoferrin on A. fumigatus corneal infection. A. Serum iron levels 24 h after
corneal infection. C57BL/6 mice were pre-treated at day -2, and day-1 with I.P. injections of iron-dextran (Fe-Dextran) or deferroxamine (Defox), and
serum iron levels were measured by spectrophotometry (data are mean +/2 SD of 5 mice per group). B. Fungal growth (dsRed A. fumigatus) and
corneal opacity in mice given Fe-Dextran or Defox. C. Metamorph image analyses of dsRed fluorescence. D. Colony forming units (CFU) per eye at
4 h and 48 h post-infection E,F. Metamorph image analyses of percent (E) and total (F) corneal opacification. G–I: Effect of lactoferrin on fungal
growth. C57BL/6 mice were infected with A. fumigatus dsRed conidia, and given topical lactoferrin (10.4 mg) at 0 and 6 h post-infection. Corneas were
examined after 24 h. G: representative images; H. image analysis of dsRed expression, and I. CFU per eye. Panels B and G show representative
images, and data points in panels C–F, H, I represent individual corneas. All panels show representative data from one experiment except for panels D
and I which show pooled data from repeat experiments. These experiments were repeated three times with similar results.
doi:10.1371/journal.ppat.1003436.g002
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To determine if this pathway is essential for fungal growth
during tissue infection, C57BL/6 mice were infected with A.
fumigatus mutant strains DsidH and DsidI and examined as before.
Figure 5B shows that mice infected with DsidH or DsidI exhibit
significantly less CFU than mice infected with the WT strain,
indicating that mevalonate incorporation into extracellular side-
rophores is essential for fungal growth during tissue infection.
Further, mice infected with either DsidH or DsidI exhibit
Figure 3. Susceptibility of A. fumigatus siderophore and iron acquisition mutants in fungal keratitis. A. Growth A. fumigatus DsidA and
DhapX mutants after incubation with human neutrophils; fungal mass was quantified using calcofluor white and fluorometry. (Mean +/2 SD of 5
replicate wells.) B–F: A. fumigatus corneal infection; G–J F. oxysporum corneal infection. B: CFU per eye of C57BL/6 mice 48 h after intrastromal
infection with A. fumigatus DsidA, DhapX, or DftrA mutants. C. Representative eyes showing corneal opacification at 24 h and 48 h. D. Representative
corneal sections stained with periodic acid-schiff and hematoxylin (PASH). E. Quantification of percent corneal opacity and F. Total cornea opacity.
G–J. C57BL/6 corneas were infected with F. oxysporum DhapX and the parent strain. G. CFU per eye at 4 h and 48 h post-infection H. Representative
eyes showing corneal opacification. I. Quantification of percent corneal opacity J. Total cornea opacity. Data points represent individual corneas. All
panels show representative data from one experiment except for panels B and G which show pooled data from repeat experiments. Similar results
were found in three repeat experiments. Abbreviations: Neuts- neutrophils, epi-epithelium, endo-endothelium, AC-anterior chamber.
doi:10.1371/journal.ppat.1003436.g003
Targeting Fungal Iron Acquisition
PLOS Pathogens | www.plospathogens.org 6 July 2013 | Volume 9 | Issue 7 | e1003436
significantly less cornea opacity at all time-points compared to
mice infected with WT A. fumigatus (Figure 5C–E). Figure S1
shows that corneas infected with the complemented DsidH strain
sidHR or the complemented DsidI strain sidIR show no significant
difference in opacification or CFU as the WT parental strain.’’
Lipocalin-1 sequesters fungal siderophores and restricts
fungal growth during infection
Humans produce two lipocalins with siderophore binding
activity [26]. Lipocalin-1 (Lcn-1) binds to a wide range of bacterial
and fungal hydroxamate-type siderophores [17], whereas Lcn-2
binds catechol-type bacterial siderophores but not fungal side-
rophores [31,32]. We therefore examined the role of Lcn-1 on A.
fumigatus using the same assays as above. Figure 6B shows
significantly less fungal growth incubated with 40 mg/ml or 4 mg/
ml Lcn-1 than in RPMI alone, and that growth of A. fumigatus in
the presence of neutrophils and 4 mg/ml Lcn-1 was significantly
less than with neutrophils alone or Lcn-1 alone. Figures 6C–E
show significantly less fungal dsRed and CFU in mice given topical
Lcn-1 (16 mg/8 ml) at 0 h and 6 h after infection compared with
infected mice not given Lcn-1. These findings indicate that topical
Lcn-1 inhibits fungal growth in vivo, presumably by sequestering
fungal siderophores.
Topical simvastatin and deferiprone inhibit fungal
infection
As shown in Figure 5, Aspergillus SidI and SidH proteins
incorporate mevalonate into the structure of extracellular side-
rophores and are essential for fungal growth in the cornea. Also,
HMG-CoA reductase is required for mevalonate production and
can be targeted by statins to inhibit siderophore biosynthesis
[14,33] (Figure 7A). To determine the effect of blocking this
Figure 4. The role of intracellular and extracellular siderophores in A. fumigatus corneal infection. A. Biosynthesis of A. fumigatus
siderophores. B–E. C57BL/6 mice infected intrastromally with A. fumigatus mutant strains DsidA, DsidC, DsidF, DsidD, or DsidG. B. CFU per eye at 4 h
and 48 h post-infection. C. Representative eyes showing corneal opacity. D. Quantification of percent corneal opacity and E. total cornea opacity. B,
D, E: Data points represent individual corneas. All panels show representative data from one experiment except for panel B which shows pooled data
from repeat experiments. Similar results were found in 3 repeat experiments. Abbreviations: Amv- anhydromevalonyl; TAFC: tri-acetyl fusarinine C.
doi:10.1371/journal.ppat.1003436.g004
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pathway on fungal growth, A. fumigatus and F. oxysporum were
incubated with the HMG-CoA reductase inhibitors simvastatin
and lovastatin, or with the iron chelators deferiprone and
deferroxamine.
As shown in Figure 7B, there was significantly less growth of A.
fumigatus following 16 h incubation in SDB media with simvastatin,
lovastatin and deferiprone, but not deferroxamine, thereby
demonstrating a direct effect of statins and deferiprone on fungal
growth. Similar results were obtained with Fusarium oxysporum
(Figure 7C). Interestingly, a statin dependent dose curve was
observed with A. fumigatus when exposed to simvastatin or
lovastatin (Figure 7B), however, a dose curve was only observed
when Fusarium was treated with simvastatin not lovastatin
(Figure 7C). This observation likely reflects differences in the
pharmacokinetics of different statins and their ability to penetrate
into the fungal cytoplasm and inhibit HMG-CoA reductase of
multiple fungal genera and species [33].
To ascertain if these agents enhance fungal sensitivity to killing
by neutrophils, A. fumigatus conidia were cultured for 4–6 h in SDB
media, washed, and incubated a further 16 h with human
neutrophils in RPMI media containing simvastatin, lovastatin or
deferiprone. As shown in Figure 7D, fungal growth was
significantly less when incubated with neutrophils and simvastatin,
lovastatin, and deferiprone compared with neutrophils alone,
whereas there was no significant difference in the presence of
deferroxamine. The inhibitory effect of 1 mM statins on fungal
growth shown in panel B was not observed in this assay, most
likely due to siderophore production during the 4–6 h growth in
the absence of statins.
To ascertain if statins can restrict fungal growth during
infection, mice were infected intrastromally with A. fumigatus, and
given topical simvastatin, deferiprone, or deferroxamine at the
time of infection and after 6 h. At 24 h post-infection, mice eyes
were imaged for corneal opacity and fungal dsRed, and processed
for fungal CFU. Importantly, unlike prior experiments, which
examined CFU at the 48 h time-point, at 24 h CFU in infected
eyes does not decrease unless treated with anti-microbial agents.
Therefore, in this 24 h assay and unlike prior experiments,
vehicle-treated CFU do not decrease but instead represent the
maximum fungal CFU value per assay. As shown in Figure 7E
and F, mice treated with simvastatin or deferiprone exhibited
significantly less fungal mass compared to vehicle-treated mice,
which was further decreased when given both compounds.
Conversely, mice given simvastatin together with deferroxamine
had significantly higher fungal mass than mice given simvastatin
alone, indicating that exogenous deferroxamine counters the
inhibitory activity of statins. Figure 7G shows similar responses
when CFU were measured 24 h post infection, with significantly
less CFU in mice given simvastatin, deferiprone or both, and
partial reversal of the inhibitory effect of simvastatin when mice
also received topical deferroxamine, indicating that simvastatin is
targeting siderophore biosynthesis in addition to ergosterol
synthesis in vivo. Mice treated with deferroxamine alone showed
elevated fungal mass (Figure 7E) compared with vehicle-treated
mice, but at this time point, CFU values were not significantly
different from vehicle-treated mice (Figure 7F). Taken together,
these findings clearly demonstrate that topical statins and iron
chelation can block fungal growth during infection.
Discussion
Previous work in our laboratory demonstrated that fungal anti-
oxidative responses are essential for survival during tissue
infection, and that fungal growth can be inhibited in vivo by
Figure 5. Role of mevalonate pathway for extracellular siderophores in A. fumigatus corneal infection. A. Mevalonate extracellular
siderophore biosynthesis pathway. B–E. C57BL/6 mice infected intrastromally with A. fumigatus DsidH and DsidI mutant strains. B. CFU per eye at 4 h
and 48 h post-infection. C. Representative eyes showing corneal opacity D. Quantification of percent corneal opacity and E. total corneal opacity. B,
D, E: Data points represent individual corneas. All panels show representative data from one experiment except for panel B which shows pooled data
from repeat experiments. Similar results were found in 3 repeat experiments. Abbreviations: HMG-CoA: 3-hydroxy-3-methyl-glutaryl-CoA.
doi:10.1371/journal.ppat.1003436.g005
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targeting fungal thioredoxin [8]. As thioredoxin-regulated perox-
iredoxases, catalases, and other antioxidants require iron to
quench reactive oxidants [9,34], the current study examined the
role of host iron sequestration and fungal iron acquisition during
infection. In examining endogenous iron levels, we found a two-
fold reduction in serum iron levels following fungal infection which
correlated with elevated expression of iron-chelating proteins,
heme-binding and siderophore-sequestering proteins in infected
corneas, and systemic induction of hepatic hepcidin. Expression of
these iron-sequestering proteins was dependent on Dectin-1,
which we and others showed is important in recognizing b-glucan
on germinating conidia [23,35,36]. Expression of these proteins
was also dependent on IL-6, which has been shown to induce liver
hepcidin and reduce systemic iron levels [15].
In this iron-restricted environment, we show that fungal
siderophores are essential for microbial growth and survival. This
notion is supported by our findings that siderophore mutants are
unable to grow in the cornea, and that exogenous iron chelators or
inhibitors of fungal siderophore biosynthesis impair fungal growth
both in vitro when incubated with human neutrophils, and in vivo
in a murine model of fungal infection. Given that the siderophore
biosynthesis pathway is highly conserved in filamentous fungi [12],
our findings are very likely relevant to fungal infections of other
tissues in addition to other fungal pathogens. Figure 8 illustrates
the fungal siderophore biosynthesis pathway and highlights the key
findings in this study.
Firstly, we identified that both Aspergillus and Fusarium require
the transcription factor HapX to sense and respond transcription-
ally to low iron levels and survive during infection. Further, we
show that A. fumigatus strains DsidF, DsidD, DsidH, or DsidI, that do
not express the extracellular siderophores are attenuated during
infection of the cornea, whereas based on the absence of a
phenotype with DsidC mutants, there is no apparent role for
intracellular siderophores. We show that production of extracel-
lular siderophores is also required for infection with Alternaria.
These findings are consistent with an essential role for HapX and
extracellular siderophores during experimental A. fumigatus lung
infection [11,14,30], the requirement of HapX for Fusarium
infection of tomato plants and immunosuppressed mice [37],
and the requirement of siderophores for Alternaria infection in
maize [38]. Interestingly, iron starvation also activates the
transcription factor AcuM, which increases HapX expression
and down-regulates the iron-repressing transcription factor SreA,
resulting in fungal iron acquisition [39]. The role of AcuM and
SreA during corneal infection has yet to be determined.
In the present study, we also examined the potential for statins
to inhibit fungal HMG-CoA reductase, which is required for
mevalonic acid production and extracellular siderophore biosyn-
thesis [14]. Consistent with a report on pulmonary aspergillosis
[14], we used mutants to demonstrate that SidI and SidH-
dependent mevalonic acid incorporation into extracellular side-
rophores is essential for infection of the cornea. Further, we show
that simvastatin and lovastatin inhibit fungal growth in vitro, and
also enhance growth inhibition by human neutrophils. Consistent
with the difference in statin activity in treating hypercholesterol-
emia [40], simvastatin exhibited 10-fold greater inhibitory activity
Figure 6. Effect of exogenous lipocalin-1 in A. fumigatus corneal infection. A. Pathway showing Lcn-1 sequestration of fungal siderophores.
B. Growth of A. fumigatus incubated with recombinant human Lcn-1 in the absence (black bars) or presence (gray bars) of human neutrophils
determined by calcofluor white binding and quantification using fluorometry (data are mean +/2SD of five replicate wells). C–E: C57BL/6 mice were
given topical Lcn-1 (16 mg) at 0 and 6 h post-infection with A. fumigatus dsRed. C. Representative corneas; D. Metamorph image analysis showing
fungal dsRed expression and E. CFU per eye. Data points represent individual corneas. All panels show representative data from one experiment
except for panel E which shows pooled data from repeat experiments. Similar results were found in two repeat experiments. Abbreviations: FusC-
fusarinine C, TAFC- tri-acetyl fusarinine C, Lcn-lipocalin.
doi:10.1371/journal.ppat.1003436.g006
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than lovastatin in restricting fungal growth in vitro. During
infection, topical application of simvastatin inhibited fungal
growth that was only partially reversed by exogenous side-
rophores, indicating that statins function in vivo by inhibiting
both fungal siderophore and ergosterol biosynthesis. The fungi-
cidal activity of statins has been reported for Aspergillus, Fusarium,
Mucorales, and Candida [41–43]. However, to our knowledge, this is
the first study to clearly demonstrate a therapeutic effect of statins
in an experimental fungal infection. In contrast to systemic statin
treatment, topical application is likely to have minimal risk of side
effects [33]. Future studies will examine if statins can restrict fungal
growth at later stages of infection.
In addition to showing inhibition of siderophore biosynthesis,
the current study demonstrates that exogenous lipocalin-1 impairs
fungal growth in the presence of human neutrophils and during
infection. This finding is consistent with the reported role for Lcn-
1 in sequestering fungal siderophores, including TAFC [17]. The
affinity of Lcn-1 for fungal siderophores is similar to that of fungal
siderophore receptors [17], and therefore at high concentrations
Lcn-1 could sequester siderophores from fungal receptors. Further,
it is likely that Lcn-1-siderophore complexes are internalized
through the lipocalin-interacting membrane receptor (LIMR)
resulting in siderophore degradation [44,45]. Endogenous Lcn-1
is abundant in human tears (3 mg/ml), nasal mucosa, and tracheal
Figure 7. Effect of topical simvastatin and deferiprone on fungal infection. A. Statin targeting of fungal HMG-CoA reductase in siderophore
biosynthesis. B, C. Effect of statins and iron chelators on growth of A. fumigatus and F. oxysporum in vitro. B. Simvastatin, lovastatin, deferiprone, or
deferroxamine were added to growing cultures of A. fumigatus or C. F. oxysporum for 16 h, and hyphal growth was quantified by calcofluor white. D.
Growth of A. fumigatus incubated with these compounds in the absence (black bars) or presence (gray bars) of human neutrophils by calcofluor
white quantification (data are mean +/2SD of five replicate wells) E. C57BL/6 mice were infected with A. fumigatus and at 0 and 6 h post-infection
13.4 mg of simvastatin (Sv), deferiprone (11.1 mg), deferroxamine (52.5 mg), Sv+ deferiprone, or Sv+ deferroxamine was applied topically to infected
corneas and eyes were imaged at 24 h post-infection. F. Metamorph image analysis was used to quantify fungal dsRed expression and G. eyes were
homogenized for CFU analysis. B–D: data are mean +/2SD of five replicate wells; F,G: data points represent individual corneas. All panels show
representative data from one experiment except for panel G which shows pooled data from repeat experiments. Similar results were found in three
repeat experiments. Abbreviations: HMG- 3-hydroxy-3-methyl-glutaryl-CoA, Sv-simvastatin, Lv-lovastatin, Dprone- deferiprone, Defox-
deferroxamine.
doi:10.1371/journal.ppat.1003436.g007
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secretions where it can function prophylactically to prevent
mucosal fungal infections [17,46]. However, as we now show that
human neutrophils express Lcn-1, it is possible that Lcn-1 also has
a protective role during active infection.
In addition to targeting siderophores, we showed that reducing
local tissue iron concentrations by topical application of the iron
chelating protein lactoferrin restricts fungal growth in vivo. This
finding is consistent with the reported role for lactoferrin in
blocking conidia germination in vitro by human neutrophils [47],
and suggests that in vivo, neutrophil-derived lactoferrin restricts the
growth of conidia and hyphae by binding free iron. Given that
siderophores exhibit a higher affinity for iron than lactoferrin [12],
it is likely that fungal siderophores can acquire iron from
lactoferrin during infection; however, the rate of siderophore iron
acquisition in a lactoferrin-rich environment is likely slower than
in the absence of lactoferrin given the scarcity of free iron or iron-
bound to lower affinity biomolecules.
Similarly, we showed that the iron chelator deferiprone sensitizes
fungi to human neutrophils and blocks fungal infection. However,
deferiprone is also a very small molecule (MW = 140 g/mole),
approximately 600-fold smaller than lactoferrin, and is therefore
released from tissues more readily than lactoferrin, resulting in both
iron sequestration and depletion from infected tissues [48]. Deferiprone
has been used effectively and safely to lower iron levels in patients with
hemochromatosis [48], and although widely utilized in Europe, it is not
currently licensed in the USA. Importantly, deferiprone, unlike
deferroxamine, is not a xenosiderophore [28] and is not associated
with an increased risk of fungal and bacterial infections [49–57].
Iron chelators have been used to treat Aspergillus and Rhizopus
infections in mice [57–60], and a clinical trial examined the
potential of the iron chelator deferasirox to enhance the efficacy of
liposomal amphotericin B to treat mucormycosis (the DEFEAT
Mucor study). However, the trial was unsuccessful due to an
unexpected increased risk of death in patients receiving deferasirox
adjunct therapy [61]. The DEFEAT Mucor study exhibited a
limited sample size and imbalanced stratification of the sickest
patients into the deferasirox treatment group and may not
accurately reflect the potential of deferasirox to treat mucormy-
cosis. However, systemic deferasirox treatment does cause side
effects that include agranulocytosis and nephrotoxicity [62]. In the
current study, we demonstrated that local (topical) application of
iron chelators is both effective in inhibiting fungal growth and
preventing corneal disease. As local administration is highly
unlikely to cause systemic side effects, clinical studies using topical
iron chelators and fungal iron acquisition inhibitors are unlikely to
cause adverse reactions, especially if combination therapies
targeting iron acquisition can use low drug concentrations. This
approach could be used to treat fungal infections not only in the
cornea, but also in other tissues that could be treated topically such
as the tongue, skin, and nails.
In conclusion, we have identified host iron sequestration and
fungal siderophore biosynthesis as essential mediators of fungal
growth during infection. One approach to exploiting these findings
is to chelate local iron at the infectious site utilizing deferiprone or
lactoferrin. A second approach is to inhibit the ability of fungi to
acquire iron utilizing the siderophore-binding protein Lcn-1 or the
Figure 8. The battle for iron between the mammalian host and fungi. Defox- deferroxamine, Dprone- deferiprone, Fe-iron, Fus C-
fusarinine C, HMG-CoA- 3-hydroxy-3methylglutaryl-coenzyme, Lcn-1- lipocalin 1, Lf- lactoferrin, NOX- nicotinamide adenine dinucleotide
phosphate oxidase, ROS-reactive oxygen species, TAFC- triacetyl fusarinine C.
doi:10.1371/journal.ppat.1003436.g008
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siderophore biosynthesis inhibitor simvastatin. However, the most
efficacious strategy would likely involve the combination of iron
chelation and inhibition of siderophore biosynthesis. In this study,
we provide proof-of-concept that dual treatment with deferiprone
and simvastatin further restricts fungal growth during infection. As
both deferiprone and simvastatin, have a long history of safe use in
patients, it is possible that these agents can be successfully utilized
to treat a broad range of fungal infections.
Materials and Methods
Use and source of animals
All animals were treated in accordance with the guidelines
provided in the Association for Research in Vision and Ophthal-
mology ARVO statement for the Use of Animals in Ophthalmic
and Vision Research, and were approved by Case Western
Reserve University IACUC. C57BL/6 mice (6–12 wk old) and IL-
62/2 mice on a C57BL/6 background were from the Jackson
Laboratory (Bar Harbor, ME), Dectin-12/2 mice were kindly
provided by Dr. Yoichiro Iwakura (University of Tokyo; Tokyo,
Japan).
Fungal strains and growth conditions
Table 1 lists the genotype and phenotype of all strains utilized
in this study. Aspergillus fumigatus was cultured on Vogel’s minimal
media (VMM) +2% agar and Fusarium oxysporum lycopersici was
cultured on potato dextrose agar (PDA). Alternaria brassicicola was
cultured in complete media as described previously [38]. All solid
media used in this study were supplemented with 10 mM FeSO4
to enhance conidia production by siderophore mutants. For
neutrophil-fungus incubation assays, all fungi were grown in
RPMI media w/o FeSO4 supplementation. The Alternaria
brassicicola Dnps2, Dnps6, and Dnps2/6 strains were kindly provided
by Dr. B. Gillian Turgeon (Cornell University, Ithaca, NY).
Mouse model of Aspergillus and Fusarium keratitis
Aspergillus and Fusarium strains were cultured as described above
for 2–3 days, and fresh conidia were disrupted with a bacterial L-
loop, harvested in 5 ml PBS, and filtered through sterile PBS-
soaked cotton gauze in a 10 ml syringe to obtain pure conidial
suspensions. Conidia were quantified using a hemocytometer and
adjusted in PBS to a final stock solution of 15–20,000 conidia/ml.
Mice were anaesthetized with 1.25% 2, 2, 2-tri-bromoethanol in
PBS. The corneal epithelium was abraded using a 30-gauge
needle, through which a 2 ml injection containing conidia was
released into the corneal stroma using a 33-gauge Hamilton
syringe. Mice were examined daily under a stereomicroscope for
corneal opacification, and quantified by image analysis using
Metamorph software as described [8,23]. At each time point,
animals were euthanized by CO2 asphyxiation, and eyes were
either placed in 10% formalin and embedded in paraffin,
sectioned at 5 mm intervals and stained with periodic acid Schiff
and Hematoxylin (PASH), or were placed in 1 ml of sterile PBS,
homogenized and colony forming units (CFU) were quantified by
manual count.
Topical and systemic drug delivery
Compounds were suspended in a commercial eye drop
formulation (Alcon laboratories) or in PBS, and 8 ml was applied
topically at 0 h and 6 h post-infection. Lactoferrin (1.25 mg/ml),
deferiprone (10 mM), deferroxamine (10 mM), and simvastatin
(4 mM) were purchased from Sigma Aldrich (St.Louis, MO).
E.coli-expressed recombinant human lipocalin-1 was purified as
described previously [17] and applied topically at 2 mg/ml. Iron-
dextran and deferroxamine were purchased from Sigma and
administered systemically to mice by daily intraperitoneal injec-
tions of 5 mg starting at day -2 until mice were euthanized. All
animals were bred under specific pathogen-free conditions and
maintained according to institutional guidelines.
Quantification of Aspergillus fungal mass and colony
forming units (CFUs)
Growth of the RFP expressing A. fumigatus strain in the cornea
was detected by fluorescent microscopy and quantified by
Metamorph image analysis [8,23]. For assessment of fungal
viability, whole eyes were homogenized under sterile conditions in
1 ml PBS, using the Mixer Mill MM300 (Retsch) at 33 Hz for
4 min. Subsequently, 100 ml aliquots were plated onto bacterio-
logic-grade Sabouraud dextrose agar plates, incubated for 24 h at
37uC (Aspergillus) or at 30uC (Fusarium and Alternaria), and the
number of CFU/eye was determined by direct counting. The
weight of the whole eye is consistent from one mouse to the next
regardless of infection, and as we homogenize the entire eye and
not just the cornea, we calculate CFU from the entire eye not just
a representative sample. Fungal dsRed and CFU analysis do not
have a linear correlation as hyphae of varying lengths show
differences in dsRed fluorescence, but are still counted as a single
CFU. Also, as homogenization can potentially damage branched
hyphae, which may be more abundant in wild type compared with
mutants, we may be underestimating the difference in CFUs
between strains. All CFU graphs show pooled data from at least
three repeat experiments.
Quantification of IL-6 protein in mouse corneas and
serum
Corneas were homogenized in 150 ml reagent diluent (R & D
Systems, Minneapolis, MN) using the Retsch MM 300 ball miller
at 33 Hz for 4 min (Qiagen). Mouse serum was obtained as
described below and assayed directly. IL-6 protein was quantified
using a mouse IL-6 ELISA kit as per manufacturer’s instructions
(R & D Systems, Minneapolis, MN).
Quantification of neutrophils in mouse corneas
Corneas were dissected, cut into 8 small fragments, and
incubated in 80 units of collaganese (Sigma-Aldrich) for 1–2 h.
The cell suspensions were filtered, centrifuged at 300*g for 5 min
at 4uC and washed in FACS buffer (PBS+1% FBS+0.5% Na
azide). Cells were then incubated with anti-mouse CD16/32
antibody (Fc block, clone 93, eBioscience) for 10 min followed
immediately by incubation with biotinylated rat anti-mouse
NIMP-R14 or isotype-control for 45 min. Cells were washed
and incubated with streptavidin-PE-Cy7 for 30 min in the dark.
Cell suspensions were then analyzed utilizing a C6 Accuri flow
cytometer with gates set based on isotype controls.
Quantitative PCR of infected corneas
C57BL/6 mice and IL-62/2 mice were infected with A.
fumigatus strain Af-dsRed as described above. At 24 h mice were
sacrificed, corneas were excised, suspended in tissue lysis buffer
(Qiagen, Valencia, CA) and homogenized using the Mixer Mill
MM300 (Retsch) at 33 Hz for 2 min. Subsequently, RNA was
extracted from samples using RNeasy mini kit according to the
manufacturer’s directions (Qiagen, Valencia, CA). Samples with a
260/280 (RNA:protein) ratio of 2.0 were used to generate cDNA
using the superscript first strand synthesis system (Life technolo-
gies, Grand Island, NY) using standard methods. Real Time PCR
was performed on the cDNA samples using the SYBR green
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system (Applied Biosystems, Carlsbad, CA). All primers used in
this study are listed in Table 2 and were synthesized by Integrated
DNA technologies (San Diego, CA). Fold change with respect to
naı̈ve uninfected corneas was calculated using the 22DDct method.
Data are therefore presented as fold increases of relative gene
expression (log (RQ)). RT-PCR samples were also analyzed by 2%
agarose gel electrophoresis.
Quantification of iron content in mouse serum
Whole blood was obtained from mice by retro-orbital bleeding,
and serum was recovered following blood coagulation. An iron
assay kit (ABCAM, Cambridge, MA) was subsequently used to
quantify Fe2+ and Fe3+ in the serum using manufacturer’s
instructions. Briefly, 25 ml of serum was added to 75 ml iron assay
buffer and 5 ml iron reducer, which reduces Fe3+ to Fe2+. Next,
100 ml of the iron-probe solution was added yielding a Fe2+-ferene
S complex that absorbs light at 593 nm. Spectrophotometry was
used to detect absorbance at this wavelength.
In vitro human neutrophil:hyphae growth inhibition
assay
Human neutrophils were isolated from normal, healthy donors
using Ficoll-Paque Plus (GE) density centrifugation as described [8].
Isolated conidia from each A. fumigatus mutant were cultured in
200 ml SDA media (12,500/well) in black-wall 96 well plates with an
optically clear bottom (CoStar 3720) until early germ tubes were
observed (4–6 h). Wells were washed twice with sterile ddH2O and
incubated 16 h with either RPMI media (+ Control), PBS (2
Control), or human peripheral blood neutrophils suspended in RPMI
at 0.5–1*105/well, which we know does not inhibit fungal growth [8].
After 16 h incubation, plates were washed and stained with 50 ml
calcofluor white stain, which binds chitin (Fluka 18909) for 5 min in
the dark. Subsequently, plates were washed three times with ddH2O
and quantified by fluorometry (360/440 nm; Synergy HT; Biotek).
In assays where no neutrophils were added, fungi were incubated in
SDA media alone with or without inhibitors. Fungi cultured in 96-
well plates exhibit maximal growth by 16 h; therefore, this assay
measures only relative decreases in fungal growth.
Statistical analysis
Statistical analysis was performed for each experiment using one
way ANOVA with a Tukey post-hoc analysis using Prism software
(GraphPad Software Inc, La Jolla, CA). A p value,0.05 was
considered significant.
Ethics statement
All animals were treated in accordance with the guidelines
provided in the Association for Research in Vision and Ophthal-
Table 1. Fungal strains utilized in this study.
Strain Genotype Phenotype
A. fumigatus
Af-dsRed [23] Af293.1- DpyrG1::gpdA::dsRed::pyrG dsRed Fluorescence
ATCC 46645 WT
DsidA [29] ATCC 46645- sidA::hph No intra or extracellular siderophores
sidAR [29] DsidA- sidA::sidA Complemented strain
DsidC [11] ATCC 46645- sidC::hph No intracellular siderophores
DsidD [11] ATCC 46645- sidD::hph No fusarinine C or TAFC
sidDR [11] DsidD- sidD::sidD Complemented strain
DsidF [11] ATCC 46645- sidF::hph No extracellular siderophores
sidFR [11] DsidF- sidF:: sidF Complemented strain
DsidG [11] ATCC 46645- sidG::hph No TAFC
DsidH [14] ATCC 46645- sidH::hph No extracellular siderophores
sidHR [14] DsidH- sidH::sidH Complemented strain
DsidI [14] ATCC 46645- sidI::hph No extracellular siderophores
sidIR [14] DsidI- sidI::sidI Complemented strain
DhapX [30] ATCC 46645- hapX::hph No hapX
hapXR [30] DhapX- hapX::hapX Complemented strain
DftrA [29] ATCC 46645- ftrA::hph No reductive iron assimilation
F. oxysporum
FoxL- 4287 [37] WT
DhapX [37] 4287- hapX::hph No hapX
hapXR [37] DhapX- hapX::hapX Complemented strain
A. brassicicola
WT-Tf383 WT
Dnps2 [38] Tf383- nps2::hph No intracellular siderophores
Dnps6 [38] Tf383- nps6::hph No extracellular siderophores
Dnps2/6 [38] Tf383- nps2::hph; nps6::hph No intra or extracellular siderophores
doi:10.1371/journal.ppat.1003436.t001
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Table 2. Primers sequences and protein function.
Primer Source (PB ID) Sequence Protein Function
Iron Chelation
Lactoferrin 141803548b2 CCGCTCAGTTGTGTCAAGAAA Binds Fe at low pH
CATGGCATCAGCTCTGTTTGT
Transferrin 118129942b1 GCTGTCCCTGACAAAACGGT Binds Fe at neutral pH
GGTATTCTCGTGCTCTGACAC
Tf receptor 1 291045184b1 GATCAAGCCAGATCAGCATTCT Internalizes transferrin
GTGTATGACAATGGTTCCCCAC
Tf receptor 2 113204629b1 CGTTGGGGTCTACTTCGGAGA Internalizes transferrin
AGATGGTCTGAGAGGGTCTTG
Lf receptor/intelectin 1 118130045b1 CAGCACTTGGGACATAATCTGT Internalizes lactoferrin
TCCTTCTCCGTATTTCACTGGG
Lipocalin-1- Human 32455234b1 ATGTGTCAGGGACGTGGTATC Binds fungal siderophores
CCGATTCCAGATTCATCTCAGG
Heme Binding Protein
Haptoglobin 254910958b1 GCACTTGGTTCGCTATCGCT Binds hemoglobin
GCCCGTAGTCTGTAGAACTGT
Hemopexin 160358828b1 AGCAGTGGCGCTAAATATCCT Binds heme
CAACTCTCCCGTTGGCAGTA
Siderophore Binding
Lipocalin-1 32455234b ATGTGTCAGGGACGTGGTATC Binds fungal siderophores
CCGATTCCAGATTCATCTCAGG
Lipocalin-2 34328048b1 GCAGGTGGTACGTTGTGGG Binds bacterial siderophores
CTCTTGTAGCTCATAGATGGTGC
Hepcidin Signaling
Interleukin 6 13624310b1 CTGCAAGAGACTTCCATCCAG Induces HAMP* synthesis
AGTGGTATAGACAGGTCTGTTGG
HFE 145966687b1 CGGGCTGCCTTTGTTTGAG Signal transductionRHAMP
CTGGCTTGAGGTTTGCTCC
BMP-2 71896668b1 TCTTCCGGGAACAGATACAGG Amplifies HAMP synthesis
TGGTGTCCAATAGTCTGGTCA
BMP-4 121949822b1 ATTCCTGGTAACCGAATGCTG ‘‘
CCGGTCTCAGGTATCAAACTAGC
BMP6 118131176b1 GCGGGAGATGCAAAAGGAGAT ‘‘
ATTGGACAGGGCGTTGTAGAG
alk1- BMPR type 1a 133891829b1 TGGCACTGGTATGAAATCAGAC BMP* receptor
CAAGGTATCCTCTGGTGCTAAAG
alk2-BMPR type 1b 41053831b1 CCTCGGCCCAAGATCCTAC ‘‘
CCTAGACATCCAGAGGTGACA
actrIIA-BMPR type 2 145966831b1 GTGTTATGGTCTGTGGGAGAAAT ‘‘
AAAGCGGTACGTTCCATTCTG
Hemojuvelin 166295197b1 ATGGGCCAGTCCCCTAGTC BMPR signaling
CAGCGGAGGATCTTGCACT
Hepcidin Blood 2010 [63] CTGAGCAGCACCACCTATCTC Degrades ferroportin
TGGCTCTAGGCTATGTTTTGC
Ferroportin 124248584b1 TGGAACTCTATGGAAACAGCCT Exports iron from cells
TGGCATTCTTATCCACCCAGT
Housekeeping gene
b-actin- Mouse 6671509a1 GGCTGTATTCCCCTCCATCG Housekeeping gene
CCAGTTGGTAACAATGCCATGT
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mology ARVO statement for the Use of Animals in Ophthalmic
and Vision Research, and were approved by Case Western
Reserve University IACUC (2011-0063). The protocol for the use
of human peripheral blood from normal healthy volunteers was
approved by the Institutional Review Board at University
Hospitals of Cleveland (07-11-21). Informed consent was obtained
in writing from each volunteer.
Supporting Information
Figure S1 Complementation of A. fumigatus and F.
oxysporum mutant strains causes phenotypic reversion
to WT parental strain phenotypes. A. C57BL/6 mice were
infected with 40,000 conidia from the WT A. fumigatus strain
ATCC 46645 and the the complemented strains: sidAR, sidDR,
sidFR, sidHR, sidIR, hapXR and CFU analysis was performed at
48 h post-infection. B. C57BL/6 mice were infected with 30,000
conidia from the WT F. oxysporum strain 4287 and the
complemented strain hapXR and CFU analysis was performed
at 48 h post-infection. C. A. fumigatus and D. F. oxysporum infected
eyes were imaged at 24 h and 48 h post-infection.
(TIFF)
Figure S2 Siderophores are required for survival of
Alternaria during infection. A. C57BL/6 mice were infected
with 40,000 conidia from the Alternaria brassicicola strain Tf383, and
the isogenic mutant strains: Dnps2 (no intracellular siderophores),
Dnps6 (no extracellular siderophores), and Dnps2/6 (no intracel-
lular or extracellular siderophores) and CFU analysis was
performed at 48 h post-infection. B. Eyes were imaged at 24 h
and 48 h post-infection C. Metamorph image analysis was used to
quantify both cornea opacity area and D. total cornea opacity.
(TIFF)
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